Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: NRX Pharmaceuticals Inc., 3 years.
NRX Pharmaceuticals Inc.
Director · CEO and Chairman
Chief executive roles
NRX Pharmaceuticals Inc.
· CEO and Chairman
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 17, 2024 | NRX Pharmaceuticals Inc. | Open-market purchase | +40,000 | $1.17 | $46,800 |
| Aug 23, 2023 | NRX Pharmaceuticals Inc. | Open-market purchase | +100,000 | $0.33 | $33,000 |
| Aug 22, 2023 | NRX Pharmaceuticals Inc. | Open-market purchase | +200,000 | $0.32 | $64,000 |
| Dec 14, 2022 | NRX Pharmaceuticals Inc. | Gift | −300,000 | — | — |
Questions about Jonathan C. Javitt
What boards is Jonathan C. Javitt on?
Jonathan C. Javitt sits on the board of NRX Pharmaceuticals Inc.
What company is Jonathan C. Javitt the CEO of?
Jonathan C. Javitt is CEO and Chairman of NRX Pharmaceuticals Inc.
How long has Jonathan C. Javitt served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.